| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |